Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas; Center for Outcomes Research, Houston Methodist, Houston, Texas.
Center for Outcomes Research, Houston Methodist, Houston, Texas.
Am J Cardiol. 2021 Dec 15;161:26-35. doi: 10.1016/j.amjcard.2021.08.067.
The long-term prognostic significance of a coronary artery calcium (CAC) score of 0 is poorly defined in younger adults. We evaluated this among participants aged 45 to 55 years from the Multi-Ethnic Study of Atherosclerosis, and assessed whether additional biomarkers can identify subgroups at increased absolute risk. We included 1,407 participants (61% women) without diabetes or severe hypercholesterolemia, with estimated 10-year risk <20% and CAC = 0. We evaluated all and hard cardiovascular disease (CVD) events, overall and among subjects with each of the following: high-sensitivity C-reactive protein levels ≥2 mg/L, homocysteine ≥10 µmol/L, high-sensitivity cardiac troponin T ≥95th percentile, lipoprotein (a) >50 mg/dl, triglycerides ≥175 mg/dl, apolipoprotein B ≥130 mg/dl, albuminuria, thoracic aortic calcium, aortic valve calcium (AVC), mitral annular calcium, ankle-brachial index <0.9, any carotid plaque, and maximum internal carotid artery intima-media thickness (ICA-IMT) ≥1.5 mm. Median follow-up was 16 years, and overall CVD event rates were low (4% at 15 years). For most exposures evaluated, rates of all CVD events were <6 per 1,000 person-years, except for ICA-IMT ≥1.5 mm (6.43) and AVC (13.8). The number needed to screen to detect ICA-IMT ≥1.5 mm was 8, and 84 for AVC. Among participants with borderline/intermediate risk or premature family history, hard CVD event rates were <7 per 1,000 for most exposures, except for ICA-IMT ≥1.5 mm (8.25), albuminuria (8.30), and AVC (13.47). Nonsmokers and those with ICA-IMT <1.5 mm had very low rates. In conclusion, our results demonstrate a favorable long-term prognosis of CAC = 0 among adults aged ≤55 years, particularly among nonsmokers. ICA-IMT testing could be considered for further risk assessment in adults ≤55 years with CAC = 0 and uncertain management.
冠状动脉钙(CAC)评分 0 分在年轻成年人中的长期预后意义尚不清楚。我们评估了多民族动脉粥样硬化研究中年龄在 45 至 55 岁的参与者,评估了是否有其他生物标志物可以识别风险增加的亚组。我们纳入了 1407 名参与者(61%为女性),无糖尿病或严重高胆固醇血症,估计 10 年风险<20%且 CAC=0。我们评估了所有和主要心血管疾病(CVD)事件,以及以下各项的发生率:高敏 C 反应蛋白水平≥2mg/L、同型半胱氨酸≥10µmol/L、高敏心肌肌钙蛋白 T 水平≥95 百分位数、脂蛋白(a)>50mg/dl、甘油三酯≥175mg/dl、载脂蛋白 B≥130mg/dl、白蛋白尿、胸主动脉钙、主动脉瓣钙(AVC)、二尖瓣环钙、踝臂指数<0.9、任何颈动脉斑块和最大颈内动脉内膜-中层厚度(ICA-IMT)≥1.5mm。中位随访时间为 16 年,整体 CVD 事件发生率较低(15 年内为 4%)。对于评估的大多数暴露因素,所有 CVD 事件的发生率均<1000 人年 6 例,除 ICA-IMT≥1.5mm(6.43)和 AVC(13.8)外。检出 ICA-IMT≥1.5mm 需要筛查的人数为 8,检出 AVC 为 84。对于边缘/中间风险或早发性家族史的参与者,大多数暴露因素的硬 CVD 事件发生率<1000 例,除 ICA-IMT≥1.5mm(8.25)、白蛋白尿(8.30)和 AVC(13.47)外。不吸烟者和 ICA-IMT<1.5mm 者发生率非常低。总之,我们的结果表明,55 岁以下成年人 CAC=0 具有良好的长期预后,尤其是不吸烟者。对于 CAC=0 且管理不确定的 55 岁以下成年人,可以考虑进行 ICA-IMT 检测以进一步评估风险。